from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0896/gltA2

LFCtreatmentdescriptionclass of inhibitor

-0.611

Amikacinug/mL Amikacintranslation

0.225

Cap5-10ug/mL Capreomycintranslation

-1.223

Rox10-50 ug/mL Roxithromycintranslation

0.357

SM2-5 ug/mL Streptomycintranslation

-1.771

Tet5-10 ug/mL Tetracyclinetranslation

-1.460

Rif0.2-5ug/mL Rifampicintranscription

-1.794

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.468

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.015

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.563

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.042

Clofazimine10-13 ug/mL Clofaziminerespiration

0.343

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.097

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.225

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.239

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.063

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.309

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.099

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.456

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.618

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.491

KCN5-20 ug/mL Potassium cyaniderespiration

1.403

NaN30.2-2 mM Sodium aziderespiration

0.261

Nigericin50 uM Nigericinrespiration

-0.058

TRC10-150 ug/mL Triclosanrespiration

-1.012

TRZ10-25 ug/mL Thioridazinerespiration

-2.123

Valinomycin0.5-10 uM Valinomycinrespiration

0.880

ZnSO42 mM ZnSO4respiration

0.394

menadione6-10 ug/mL Menadionerespiration

-1.018

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.178

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.843

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.404

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.806

NRP_1Non-replicating persistence stage 1dosRassociated

0.145

Amp0.2mg/mL AmpicillincellWall

-0.006

Cephalexin20-100 ug/mL CephalexincellWall

0.189

Cerulenin0.32-5 ug/mL CerulenincellWall

0.511

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.213

EMB10-20 ug/mL EthambutolcellWall

-0.075

Eta12-40 ug/mL EthionamidecellWall

-0.516

INH0.2-0.4 ug/mL IsoniazidcellWall

0.524

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.519

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.511

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.808

BZA0.12 mg/mL BenzamidearomaticAmides

0.754

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.874

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.632

H2O24 mM hydrogen peroxideDNAdamaging

1.038

Levo10 ug/mL LevofloxacinDNAdamaging

0.573

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.304

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.180

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.367

UVUV-irradiationDNAdamaging

-1.734

ARP41-4 ug/mL Antitubercular compound ARP4?

0.309

Antimycin12.5-50 ug/mL Antimycin A?

0.001

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.008

PA_110-50 ug/mL Antitubercular compound PA-1?

0.919

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.334

PA8240.2-2 ug/mL PA-824?

0.541

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.338

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.514

Verapamil50 uM Verapamil?

0.241

mercaptoethanol2 mM 2-Mercaptoethanol?

0.183

methoxatin10-20 ug/mL Methoxatin?